Hepatocellular carcinoma in Native South Asian Pakistani population; Trends, clinico-pathological characteristics & differences in viral marker negative & viral-hepatocellular carcinoma

BMC Research Notes

Volumn 6, Issue 1, 2013, Pages

  Butt, Amna Subhan ^a   Hamid, Saeed ^a   Wadalawala, Ashfaq Ahmad ^a   Ghufran, Mariam ^a   Javed, Ammar Asrar ^b   Farooq, Omer ^a   Ahmed, Bilal ^a   Haq, Tanveer Ul ^b   Jafri, Wasim ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^b AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Hepatitis B; Hepatitis C; Hepatocellular Carcinoma; Pakistan; Viral marker negative HCC; Viral HCC

Indexed keywords

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LIVER NEOPLASMS; MALE; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PAKISTAN; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; VERY ELDERLY; VIROLOGY; YOUNG ADULT; ARTICLE; LIVER CELL CARCINOMA; LIVER TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PAKISTAN; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84875849423     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-6-137     Document Type: Article

References (37)

1. Management of Hepatocellular Carcinoma: An Update. Bruix JSM, Hepatology 2010 00 00 1 35
2. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Raza SA, Clifford GM, Franceschi S, Br J Cancer 2007 96 7 1127 1134 10.1038/sj.bjc. 6603649 17406349 (Pubitemid 46608308)
3. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma. Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A, Yamaguchi A, Isogai M, Kaneoka Y, J Gastroenterol Hepatol 2008 23 3 459 466 10.1111/j.1440-1746.2007.05138.x 17854425 (Pubitemid 351342069)
4. Hepatitis B virus-related hepatocellular carcinoma: epidemiology and pathogenic role of viral factors. Liu CJ, Kao JH, J Chin Med Assoc 2007 70 4 141 145 10.1016/S1726-4901(09)70346-6 17475593
5. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients. Dohmen K, Shigematsu H, Irie K, Ishibashi H, Hepatogastroenterology 2003 50 54 2022 2027 14696457 (Pubitemid 37467986)
6. Clinicopathologic study on hepatocellular carcinoma negative for hepatitis B surface antigen and antibody to hepatitis C virus. Noguchi K, Nakashima O, Nakashima Y, Shiota K, Nawata H, Kojiro M, Int J Mol Med 2000 6 6 661 665 11078825
7. Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion. Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, Hamamura K, Imai Y, Yoshida H, Shiina S, Hepatology 2000 32 6 1216 1223 10.1053/jhep.2000. 20237 11093727
8. Prevention of hepatocellular carcinoma. Wands JR, N Engl J Med 2004 351 15 1567 1570 10.1056/NEJMe048237 15470221 (Pubitemid 39315325)
9. Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray. Iizuka N, Oka M, Yamada-Okabe H, Hamada K, Nakayama H, Mori N, Tamesa T, Okada T, Takemoto N, Matoba K, Int J Oncol 2004 24 3 565 574 14767541
10. Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis. Benvegnu L, Alberti A, Antiviral Res 2001 52 2 199 207 10.1016/S0166-3542(01)00185-1 11672830 (Pubitemid 32973695)
11. Hepatitis B e antigen and the risk of hepatocellular carcinoma. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ, N Engl J Med 2002 347 3 168 174 10.1056/NEJMoa013215 12124405 (Pubitemid 34764820)
12. Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma. Cantarini MC, Trevisani F, Morselli-Labate AM, Rapaccini G, Farinati F, Del Poggio P, Di Nolfo MA, Benvegnu L, Zoli M, Borzio F, Am J Gastroenterol 2006 101 1 91 98 10.1111/j.1572-0241.2006.00364.x 16405539 (Pubitemid 43381714)
13. Clinical characteristics of NonBNonC- HCC: Comparison with HBV and HCV related HCC. Hatanaka K, Kudo M, Fukunaga T, Ueshima K, Chung H, Minami Y, Sakaguchi Y, Hagiwara S, Orino A, Osaki Y, Intervirology 2007 50 1 24 31 10.1159/000096309 17164554 (Pubitemid 46005268)
14. Screening in liver disease: report of an AASLD clinical workshop. Adams PC, Arthur MJ, Boyer TD, DeLeve LD, Di Bisceglie AM, Hall M, Levin TR, Provenzale D, Seeff L, Hepatology 2004 39 5 1204 1212 10.1002/hep.20169 15122748 (Pubitemid 38569041)
15. Spectrum of hepatocellular carcinoma at Shifa International Hospital. Khokhar N, Aijazi I, Gill ML, Islamabad. J Ayub Med Coll Abbottabad 2003 15 4 1 4
16. Radiological features of hepatocellular carcinoma in Southern Pakistan. Sharieff S, Burney KA, Ahmad N, Salam A, Siddiqui T, Trop Doct 2001 31 4 224 225 11676064 (Pubitemid 32980365)
17. Prevalence of hepatitis B surface antigen and HCV antibodies in hepatocellular carcinoma cases in Karachi. Abdul Mujeeb S, Jamal Q, Khanani R, Iqbal N, Kaher S, Pakistan. Trop Doct 1997 27 1 45 46 (Pubitemid 27064371)
18. The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellular carcinoma. Tong CY, Khan R, Beeching NJ, Tariq WU, Hart CA, Ahmad N, Malik IA, Epidemiol Infect 1996 117 2 327 332 10.1017/S0950268800001503 8870630 (Pubitemid 26345242)
19. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma. Hussain K, El-Serag HB, Minerva Gastroenterol Dietol 2009 55 2 123 138 19305372
20. Management of hepatocellular carcinoma. Bruix J, Sherman M, Hepatology 2005 42 5 1208 1236 10.1002/hep.20933 16250051 (Pubitemid 43112690)
21. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Shaheen AA, Myers RP, Hepatology 2007 46 3 912 921 10.1002/hep.21835 17705266 (Pubitemid 47436137)
22. Transection of the oesophagus for bleeding oesophageal varices. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R, Br J Surg 1973 60 8 646 649 10.1002/bjs.1800600817 4541913
23. Many staging systems for hepatocellular carcinoma: evolution from Child-Pugh. Dohmen K, Okuda to SLiDe. J Gastroenterol Hepatol 2004 19 11 1227 1232 10.1111/j.1440-1746.2004.03538.x (Pubitemid 39481754)
24. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Trevisani F, De NS, Rapaccini G, Farinati F, Benvegnu L, Zoli M, Grazi GL, Del PP, Di N, Bernardi M, Am J Gastroenterol 2002 97 3 734 744 10.1111/j.1572-0241.2002.05557.x 11922571 (Pubitemid 34245906)
25. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L, N Engl J Med 1996 334 11 693 699 10.1056/NEJM199603143341104 8594428 (Pubitemid 26079803)
26. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Llovet JM, Fuster J, Bruix J, Liver Transpl 2004 10 2 Suppl 1 115 120 14762851
27. Hosmer DW, LS: Applied Logistic regression New York: Wiley and Sons 1989
28. Recent trend of clinical features in patients with hepatocellular carcinoma. Nagaoki Y, Hyogo H, Aikata H, Tanaka M, Naeshiro N, Nakahara T, Honda Y, Miyaki D, Kawaoka T, Takaki S, Hepatol Res 2012 42 4 368 375 10.1111/j.1872-034X.2011.00929.x 22151896
29. Hepatocellular Carcinoma. Sharieff S, Burney I, Salam ATS, J Coll Physicians Surg Pak 2002 12 5 264 267 (Pubitemid 34625063)
30. Sero-Prevalence of Hepatitis B and C Viruses in Hepatocellular Carcinoma. Mumtaz MSIR, Umar M, Khar B, Mumtaz MO, Anwar F, Zulfiqar S, Ejaz S, Hanif S, Khan MA, Mazhar S, Abassi S, J Rawal Med Coll 2001 5 2 78 80
31. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS, Hepatology 2002 36 6 1349 1354 12447858 (Pubitemid 35403524)
32. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB, Gastroenterology 2004 127 5 1372 1380 10.1053/j.gastro.2004.07.020 15521006 (Pubitemid 39457763)
33. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Seeff LB, Hoofnagle JH, Oncogene 2006 25 27 3771 3777 10.1038/sj.onc.1209560 16799618 (Pubitemid 43980472)
34. Differences in prognostic factors according to viral status in patients with hepatocellular carcinoma. Akahoshi H, Taura N, Ichikawa T, Miyaaki H, Akiyama M, Miuma S, Ozawa E, Takeshita S, Muraoka T, Matsuzaki T, Oncol Rep 2010 23 5 1317 1323 20372846
35. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. Trevisani F, Magini G, Santi V, Morselli-Labate AM, Cantarini MC, Di Nolfo MA, Del Poggio P, Benvegnu L, Rapaccini G, Farinati F, Am J Gastroenterol 2007 102 5 1022 1031 10.1111/j.1572-0241.2007.01100.x 17313497 (Pubitemid 46698223)
36. Hepatitis viral status affects the pattern of intrahepatic recurrence after resection for hepatocellular carcinoma. Wakai T, Shirai Y, Yokoyama N, Nagakura S, Hatakeyama K, Eur J Surg Oncol 2003 29 3 266 271 10.1053/ejso.2002.1395 12657238 (Pubitemid 36395563)
37. Analysis of background factors and evaluation of a population at high risk of hepatocellular carcinoma. Miyazawa K, Moriyama M, Mikuni M, Matsumura H, Aoki H, Shimizu T, Yamagami H, Kaneko M, Shioda A, Tanaka N, Intervirology 2003 46 3 150 156 10.1159/000071455 12867752 (Pubitemid 36928644)